Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Traffic Injury Prevention|August 24, 2010
Considerations of "Combined Probability of Injury" in the next-generation USA frontal NCAPTony R Laituri, Scott Henry, Kaye Sullivan, et al.Stapp Car Crash Journal|February 22, 2007
Derivation and theoretical assessment of a set of biomechanics-based, AIS2+ risk equations for the knee-thigh-hip complexTony R Laituri, Scott Henry, Kaye Sullivan, et al.Expert Opinion on Drug Metabolism & Toxicology|May 31, 2019
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense OligonucleotidesYanfeng Wang, Rosie Z Yu, Scott Henry, et al.Nucleic Acid Therapeutics|August 20, 2014
Considerations for assessment of reproductive and developmental toxicity of oligonucleotide-based therapeuticsJoy Cavagnaro, Cindy Berman, Doug Kornbrust, et al.Sports Medicine - Open|July 9, 2025
The Coach's Eye: A Randomized Repeated-Measure Observational Study Assessing Coaches' Perception of Velocity Loss During Resistance Training ExercisesAntonio Dello Iacono, Scott Henry, Asaf Ben-Ari, et al.Sports Medicine - Open|March 11, 2026
Sharpening the Coach's Eye: An Observational Study Investigating the Trainability of An Eye-Tracking Strategy for Perceiving Barbell Velocity Loss in Resistance TrainingAsaf Ben-Ari, Scott Henry, Israel Halperin, et al.Stapp Car Crash Journal|November 22, 2016
New Risk Curves for NHTSA's Brain Injury Criterion (BrIC): Derivations and AssessmentsTony R Laituri, Scott Henry, Kevin Pline, et al.Current Eye Research|June 6, 2003
Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularizationRonald Danis, Mark Criswell, Faruk Orge, et al.Stapp Car Crash Journal|December 15, 2015
Derivation of a Provisional, Age-dependent, AIS2+ Thoracic Risk Curve for the THOR50 Test Dummy via Integration of NASS Cases, PMHS Tests, and Simulation DataTony R Laituri, Scott Henry, Raed El-Jawahri, et al.Journal of Clinical Pharmacology|April 4, 2017
Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal AdministrationsKenneth T Luu, Daniel A Norris, Rudy Gunawan, et al.Pageof 3